Tardive dystonic syndrome induced by the calcium-channel blocker amlodipine

Journal of Neural Transmission

Volumn 121, Issue 4, 2014, Pages 367-369

  Dressler, Dirk ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Akathisia; Amlodipine; Anxiety; Breathing dysrhythmia; Calcium channel blocker; Depression; Dopamine blockade; Tardive dystonia

Indexed keywords

AGED; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; FEMALE; HUMANS; HYPERTENSION; MALE; MOVEMENT DISORDERS;

EID: 84898896898     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-013-1108-8     Document Type: Article

References (8)

1. Bondon-Guitton E, Perez-Lloret S, Bagheri H, Brefel C, Rascol O, Montastruc JL (2011) Drug-induced Parkinsonism: a review of 17 years' experience in a regional pharmacovigilance center in France. Mov Disord 26:2226-2231
2. De Melo-Souza SE (1984) Flunarizina, Parkinsonismo e Depressão. In: XI Congresso Brasileiro de Neurologia (Resumos), Goiânia
3. Essali A, Deirawan H, Soares-Weiser K, Adams CE (2011) Calcium channel blockers for neuroleptic-induced tardive dyskinesia. Cochrane Database Syst Rev. CD000206. doi: 10.1002/14651858.CD000206.pub3
4. Fabiani G, Pastro PC, Froehner C (2004) Parkinsonism and other movement disorders in outpatients in chronic use of cinnarizine and flunarizine. Arq Neuropsiquiatr 62:784-788
5. Fleckenstein A (1983) History of calcium antagonists. Circ Res 52:I3-I16
6. Micheli F, Pardal MF, Gatto M, Torres M, Paradiso G, Parera IC, Giannaula R (1987) Flunarizine- and cinnarizine-induced extrapyramidal reactions. Neurology 37:881-884
7. Negrotti A, Calzetti S (1997) A long-term follow-up study of cinnarizine- and flunarizine-induced Parkinsonism. Mov Disord 12:107-110
8. Pina MA, Ara JR, Remírez A, Castiella J (1998) Verapamil and acute dystonia. J Clin Pharm Ther 23:79-80